Medicine's psychedelic renaissanceFor 50 years, virtually all medical research into psychedelic substances stopped. That research has now been renewed—and these radical therapies are again threatening to upend accepted clinical wisdom Medical association honoraria: Are they fair or too high?CMA refuses to reveal board payments even though OMA and others do Bleeding risk increased with dabigatran-statin combo Study of Ontario seniors suggests caution needed with simvastatin and lovastatin Canadian surgeons preserve donor lungs for more than 12 hours Ex-vivo lung perfusion abolishes geographical boundaries to lung retrieval in North America Nova Scotia pharmacy program in national spotlight following death of young Ontario boy Health minister directs college to reach out to eastern counterpart to learn more about mandatory quality assurance program SafetyNET-RX. A look at how up to date provinces keep their opioid overdose numbers How current the provinces have kept statistics around deaths. Lack of comparable opioid overdose stats across Canada hinders response: experts Provinces use “hodgepodge” of different methods to track overdoses. Cold FX makers convince B.C. judge to reject class action application Man launched claim in 2012 over cold and flu advertising claim. Most Canadians high on Shoppers' bid to sell medical marijuana Young adults, wealthiest Canadians most in favour of drugstore chain's formal application. High-intensity end-of-life care more common for children than adults First Previous 396 397 398 399 400 Next Last
